Join the club for FREE to access the whole archive and other member benefits.

Neuralink's brain implant gets $280M in funding, eyes clinical trials


Key points from article :

Neuralink, the Elon Musk-founded company developing brain implants, has raised $280 million in a new funding round.

The funding was led by Founders Fund, a venture capital firm co-founded by Peter Thiel.

Despite earlier delays and skepticism from some former employees, Neuralink has now received FDA's green light for trials.

The new funding will be used to support Neuralink's clinical trials of its brain implant.

This latest funding round increases Neuralink's total funding well beyond the half-billion-dollar mark.

Neuralink has yet to begin enrolment for the clinical trial, but interested individuals can enrol in its registry.

FDA approves Neuralink's brain implant, patients can now sign up for trials

Mentioned in this article:

Click on resource name for more details.

Food and Drug Administration (FDA)

Ensuring safety of drugs, medical supplies and food which is used daily.

Founders Fund

Generalist firm investing in companies across all sectors


Company developing high bandwidth brain-machine interfaces to connect humans and machines.

Neuralink's brain implant gets $280M in funding, eyes clinical trials